Inhibrx Biosciences (INBX) traded down -3.83 % during a 24 hours period ending at 07:47 PM Central Europe on Monday 26th. One Inhibrx Biosciences stock can currently be bought for about USD 88.03 on popular exchanges. Current supply of Inhibrx Biosciences stocks is 14.7 mn. Inhibrx Biosciences has a current market capitalization of USD 1.4 bn and approximately USD 16.5 mn worth of Inhibrx Biosciences was traded on exchanges in the last 24 hours. Since last month end, Inhibrx Biosciences has traded -6.99 % down. Simple moving average of last 200 days is at USD 91.99. The highest price of past 52 weeks was recorded at USD 155.29 on 04/22/2026. 52 weeks low was at USD 57.3 on 03/27/2026.
Here is how related stocks have performed in the past 24 hours:
Connectone (CNOB) traded down -0.4 % and now trades at USD 32.81. Current market capitalisation for Connectone is USD 1.6 bn. Connectone has a current price to earnings ratio of 11.46.
Sixth Specialty Lendi (TSLX) traded down -1.67 % and now trades at USD 16.88. Current market capitalisation for Sixth Specialty Lendi is USD 1.6 bn. Sixth Specialty Lendi has a current price to earnings ratio of 18.13.
Forte Biosciences (FBRX) traded up 0.03 % and now trades at USD 76.99. Forte Biosciences has a market capitalisation of USD 1.6 bn.
Live Oak Bancshares (LOB) traded down -1.57 % and now trades at USD 35.24. Live Oak Bancshares has a market capitalisation of USD 1.6 bn. Current price/earnings ratio for Live Oak Bancshares is 12.49.
Sonida Senior Living (SNDA) traded down -0.15 % and now trades at USD 33.49. Current market capitalisation for Sonida Senior Living is USD 1.6 bn.
